Frontiers in Pharmacology · 2019 · 54 citations · 34 references
MedicineOncologyPharmacologyCancer PharmacologyCarcinogenesisMolecular OncologyKidney CancerOncogenic Signaling PathwaysRenal Cell CarcinomaAnticancer ActivityApoptosis In Renal CellsCancer Cell Proliferation InhibitionCell Cycle Arrest MechanismsCell Cycle Arrest SignalingCell Cycle InhibitionFlavonoid GlycosidesImmunofluorescence Findings
Nobiletin is a polymethoxy flavonoid isolated from Citrus depressa and Citrus reticulata. It has been reported that nobiletin can suppress tumors. We primarily explored the antitumor effects of nobiletin and the associated potential mechanisms in ACHN and Caki-2 renal carcinoma cells. A CCK-8 assay and cloning experiments were used to assess cell viability, and a transwell assay and scratch test were used to assess metastatic ability. The cell cycle was analyzed by flow cytometry, while apoptosis was analyzed using flow cytometry and a TUNEL assay. Protein expression was examined by western blot and immunofluorescence. Renal cancer cells were subcutaneously transplanted into nude mice for in vivo studies. The data showed that nobiletin administration significantly dose- and time-dependently suppressed renal cancer cell proliferation; moreover, nobiletin treatment induced cell cycle arrest in the G0/G1 phase and promoted apoptosis. Immunofluorescence analysis indicated that nobiletin decreased the nuclear localization of signal transducer and activator of transcription 3 (STAT3) and YY1-associated protein 1 (YY1AP1). Western blot showed that the levels of phosphorylated SRC, phosphorylated AKT serine/threonine kinase (AKT), and phosphorylated STAT3 were decreased, whereas that of phosphorylated YY1AP1 was increased. The results further showed that application of insulin-like growth factor 1 (IGF1) was able to reverse the nobiletin-induced changes in the levels of phosphorylated AKT, phosphorylated STAT3, and phosphorylated YY1AP1, and could also reverse the antitumor effects of nobiletin. The results of in vivo experiments showed that, compared to the control, tumor volume and weight were both reduced following nobiletin treatment. In conclusion, our study demonstrated that nobiletin can inhibit renal carcinoma cell viability and provides a novel therapeutic approach for the treatment of kidney cancer.
34
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text
The Global Burden of Cancer 2013
Christina Fitzmaurice, Daniel Dicker, Amanda Pain et al. · JAMA Oncology · 2015 · 2.8K citations · Full text
Obesity, Hypertension, and the Risk of Kidney Cancer in Men
Wong‐Ho Chow, Gloria Gridley, Joseph F. Fraumeni et al. · New England Journal of Medicine · 2000 · 675 citations
Medicine, Nephrology, Oncology +14
Flavonoid Composition of Fruit Tissues of Citrus Species
Yoichi Nogata, Koji Sakamoto, Hiroyuki Shiratsuchi et al. · Bioscience Biotechnology and Biochemistry · 2006 · 662 citations · Full text
Agriculture, Botany, Plant Sciences +17